These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interaction between aminergic systems in mesolimbic structures: the importance of 5-HT2, D2 and D1 receptors in the olfactory tubercle for the atypical profile of neuroleptics. Cools AR; Prinssen E; Ellenbroek BA Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():618A-619A. PubMed ID: 1354068 [TBL] [Abstract][Full Text] [Related]
6. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs]. Płaźnik A; Kostowski W Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150 [No Abstract] [Full Text] [Related]
7. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors. Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199 [No Abstract] [Full Text] [Related]
8. The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems. Tricklebank MD Behav Brain Res; 1996; 73(1-2):15-7. PubMed ID: 8788471 [TBL] [Abstract][Full Text] [Related]
10. Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Roth RH Commun Psychopharmacol; 1979; 3(6):429-45. PubMed ID: 44693 [No Abstract] [Full Text] [Related]
11. [Biochemical mechanism of action of neuroleptics (author's transl)]. Scatton B Encephale; 1981; 7(3):201-14. PubMed ID: 6116590 [TBL] [Abstract][Full Text] [Related]
12. Regional selectivity of neuroleptic drugs: an argument for site specificity. Borison RL; Diamond BI Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135 [TBL] [Abstract][Full Text] [Related]
13. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. Chouinard G; Jones BD Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522 [TBL] [Abstract][Full Text] [Related]
14. Is there a limbic system equivalent of tardive dyskinesia? Davis KL; Rosenberg GS Biol Psychiatry; 1979 Aug; 14(4):699-703. PubMed ID: 39641 [TBL] [Abstract][Full Text] [Related]
15. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Ceci A; Smith M; French ED Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063 [TBL] [Abstract][Full Text] [Related]
16. [Effect of long-term neuroleptic administration on CNS receptors plasticity]. Allikmets LKh; Zharkovskiĭ AM; Nurk AM; Vasar EE; Maĭmets MO Vestn Akad Med Nauk SSSR; 1984; (11):37-42. PubMed ID: 6152099 [No Abstract] [Full Text] [Related]
17. Is amisulpride an 'atypical' atypical antipsychotic agent? Lecrubier Y Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520 [TBL] [Abstract][Full Text] [Related]
18. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain. Borison RL; Fields JZ; Diamond BI Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643 [No Abstract] [Full Text] [Related]
19. Effect of chronic treatment with typical and atypical neuroleptics on the expression of dopamine D2 and D3 receptors in rat brain. Hurley MJ; Stubbs CM; Jenner P; Marsden CD Psychopharmacology (Berl); 1996 Dec; 128(4):362-70. PubMed ID: 8986007 [TBL] [Abstract][Full Text] [Related]
20. [Dopamine hypothesis in schizophrenia--recent findings in limbic system abnormality]. Toru M; Watanabe S; Kaneno S Nihon Rinsho; 1978; 36(1):76-82. PubMed ID: 24768 [No Abstract] [Full Text] [Related] [Next] [New Search]